Table III.
Characteristic | Clinical improvement (n = 2187; 83.9%) | LCI (n = 420; 16.1%) | P value |
---|---|---|---|
Follow-up, days | 49 (42-78) | 49 (39-103) | .14 |
VCSS after treatment | 2 (1-4) | 6 (5-8) | < .001 |
VCSS delta | 4.00 (3.00-6.00) | 0.00 (−1.00 to 0.0) | < .001 |
LCI based on VVSymQ | 137 (6.8) | 89 (23) | < .001 |
Complications | |||
Blistering | 2 (0.1) | 0 (0) | > .9 |
DVT | 7 (0.4) | 3 (1.0) | .2 |
Hematoma | 7 (0.4) | 2 (0.7) | .4 |
Paresthesia | 24 (1.4) | 4 (1.4) | > .9 |
Pigmentation | 23 (1.3) | 2 (0.7) | .6 |
Phlebitis | 21 (1.2) | 8 (2.7) | .054 |
Ulcer | 0 (0) | 2 (0.7) | .02 |
Wound | 8 (0.5) | 1 (0.3) | > .9 |
Proximal thrombus extension | 40 (2.3) | 2 (0.7) | .078 |
Any complication | 128 (5.9) | 23 (5.5) | .8 |
Compression therapy after treatment | < .001 | ||
Daily | 397 (18) | 193 (46) | |
Almost daily | 359 (16) | 117 (28) | |
Intermittent | 604 (28) | 69 (16) | |
None | 827 (38) | 41 (9.8) | |
Vein recanalization | 9 (0.4) | 7 (1.7) | < .001 |
Quality of life | |||
Heaviness | 541 (26) | 204 (52) | < .001 |
Achiness | 862 (42) | 272 (69) | < .001 |
Swelling | 756 (37) | 254 (64) | < .001 |
Throbbing | 357 (17) | 150 (38) | < .001 |
Itching | 342 (17) | 136 (34) | < .001 |
DVT, Deep vein thrombosis; LCI, lack of clinical improvement.
Data presented as median (interquartile range) or number (%).
Boldface P values represent statistical significance (P < .05).